---
title: "Oprelvekin - Thrombocytopenic disorder - 2"
sidebar: mydoc_sidebar
permalink: db00038-mesh-d013921-2.html
toc: false 
---


Path ID: `DB00038_MESH_D013921_2`
{% include image.html url="images/db00038-mesh-d013921-2.png" file="db00038-mesh-d013921-2.png" alt="db00038-mesh-d013921-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C105308 | oprelvekin | Drug |
| UniProt:Q14626 | Interleukin-11 receptor subunit alpha | Protein |
| GO:0004921 | interleukin-11 receptor activity | MolecularActivity |
| GO:0035726 | common myeloid progenitor cell proliferation | BiologicalProcess |
| MESH:D034061 | Thrombopoiesis | BiologicalProcess |
| MESH:D013921 | Thrombocytopenic disorder | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Oprelvekin | INCREASES ACTIVITY OF | Interleukin-11 Receptor Subunit Alpha |
| Interleukin-11 Receptor Subunit Alpha | POSITIVELY REGULATES | Interleukin-11 Receptor Activity |
| Interleukin-11 Receptor Activity | POSITIVELY CORRELATED WITH | Common Myeloid Progenitor Cell Proliferation |
| Common Myeloid Progenitor Cell Proliferation | POSITIVELY CORRELATED WITH | Thrombopoiesis |
| Thrombopoiesis | NEGATIVELY CORRELATED WITH | Thrombocytopenic Disorder |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00038#mechanism-of-action](https://go.drugbank.com/drugs/DB00038#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Oprelvekin](https://en.wikipedia.org/wiki/Oprelvekin)
